188 related articles for article (PubMed ID: 22070699)
1. Tele-assessment of Psoriasis Area and Severity Index: a study of the accuracy of digital image capture.
Singh P; Soyer HP; Wu J; Salmhofer W; Gilmore S
Australas J Dermatol; 2011 Nov; 52(4):259-63. PubMed ID: 22070699
[TBL] [Abstract][Full Text] [Related]
2. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index.
Berth-Jones J; Thompson J; Papp K;
Br J Dermatol; 2008 Aug; 159(2):407-12. PubMed ID: 18565187
[TBL] [Abstract][Full Text] [Related]
3. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased.
Jacobson CC; Kimball AB
Br J Dermatol; 2004 Aug; 151(2):381-7. PubMed ID: 15327545
[TBL] [Abstract][Full Text] [Related]
4. A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.
Berth-Jones J; Grotzinger K; Rainville C; Pham B; Huang J; Daly S; Herdman M; Firth P; Hotchkiss K
Br J Dermatol; 2006 Oct; 155(4):707-13. PubMed ID: 16965419
[TBL] [Abstract][Full Text] [Related]
5. Interobserver reliability of the Nail Psoriasis Severity Index.
Aktan S; Ilknur T; Akin C; Ozkan S
Clin Exp Dermatol; 2007 Mar; 32(2):141-4. PubMed ID: 17137477
[TBL] [Abstract][Full Text] [Related]
6. Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters.
Armstrong AW; Parsi K; Schupp CW; Mease PJ; Duffin KC
JAMA Dermatol; 2013 May; 149(5):577-82. PubMed ID: 23426158
[TBL] [Abstract][Full Text] [Related]
7. Application of machine vision to assess involved surface in patients with psoriasis.
Savolainen L; Kontinen J; Röning J; Oikarinen A
Br J Dermatol; 1997 Sep; 137(3):395-400. PubMed ID: 9349336
[TBL] [Abstract][Full Text] [Related]
8. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
[TBL] [Abstract][Full Text] [Related]
9. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment.
Langley RG; Ellis CN
J Am Acad Dermatol; 2004 Oct; 51(4):563-9. PubMed ID: 15389191
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin for the treatment of plaque-type psoriasis.
Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
[TBL] [Abstract][Full Text] [Related]
12. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.
Bożek A; Reich A
Adv Clin Exp Med; 2017 Aug; 26(5):851-856. PubMed ID: 29068583
[TBL] [Abstract][Full Text] [Related]
13. Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.
Walsh JA; McFadden M; Woodcock J; Clegg DO; Helliwell P; Dommasch E; Gelfand JM; Krueger GG; Duffin KC
J Am Acad Dermatol; 2013 Dec; 69(6):931-7. PubMed ID: 24054760
[TBL] [Abstract][Full Text] [Related]
14. Intra- and interobserver variability of image-based PASI assessments in 120 patients suffering from plaque-type psoriasis.
Fink C; Alt C; Uhlmann L; Klose C; Enk A; Haenssle HA
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1314-1319. PubMed ID: 29569769
[TBL] [Abstract][Full Text] [Related]
15. Precision and reproducibility of automated computer-guided Psoriasis Area and Severity Index measurements in comparison with trained physicians.
Fink C; Alt C; Uhlmann L; Klose C; Enk A; Haenssle HA
Br J Dermatol; 2019 Feb; 180(2):390-396. PubMed ID: 30218575
[TBL] [Abstract][Full Text] [Related]
16. A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients.
Louden BA; Pearce DJ; Lang W; Feldman SR
Dermatol Online J; 2004 Oct; 10(2):7. PubMed ID: 15530297
[TBL] [Abstract][Full Text] [Related]
17. Objective assessment of psoriasis erythema for PASI scoring.
Ahmad Fadzil MH; Ihtatho D; Mohd Affandi A; Hussein SH
J Med Eng Technol; 2009; 33(7):516-24. PubMed ID: 19639508
[TBL] [Abstract][Full Text] [Related]
18. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison.
Gottlieb AB; Chaudhari U; Baker DG; Perate M; Dooley LT
J Drugs Dermatol; 2003 Jun; 2(3):260-6. PubMed ID: 12848110
[TBL] [Abstract][Full Text] [Related]
19. Etanercept treatment for children and adolescents with plaque psoriasis.
Paller AS; Siegfried EC; Langley RG; Gottlieb AB; Pariser D; Landells I; Hebert AA; Eichenfield LF; Patel V; Creamer K; Jahreis A;
N Engl J Med; 2008 Jan; 358(3):241-51. PubMed ID: 18199863
[TBL] [Abstract][Full Text] [Related]
20. Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis.
Gourraud PA; Le Gall C; Puzenat E; Aubin F; Ortonne JP; Paul CF
J Invest Dermatol; 2012 Sep; 132(9):2171-5. PubMed ID: 22592157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
